Caroline K Thoreson1, Stephanie T Chung1, Madia Ricks1, James C Reynolds2, Alan T Remaley3, Vipul Periwal4, Yanjun Li4, Anne E Sumner1. 1. Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH), Bethesda, MD 20892. 2. Nuclear Medicine Division, Radiology and Imaging Sciences Department, Clinical Center, NIH, Bethesda, MD 20892. 3. Lipoprotein Metabolism Section, Cardiopulmonary Branch, National Heart Lung Blood Institute, NIH, Bethesda, MD 20892. 4. Laboratory of Biological Modeling, Computational Medicine Section, NIDDK, NIH, Bethesda, MD 20892.
Abstract
UNLABELLED: African ancestry is associated with low vitamin D levels but high bone density. Fifty percent of African immigrants had low vitamin D levels, but <10 % had evidence of deficiency. The value of providing vitamin D supplementation to African immigrants without evidence of deficiency needs to be determined. INTRODUCTION: The Endocrine Society and Institute of Medicine (IOM) have concluded from studies in largely white populations that 25(OH)D is necessary for bone health. However, their definition of vitamin D insufficiency differs. The Endocrine Society recommends a 25(OH)D threshold of <30 ng/mL. The IOM uses a lower threshold of 25(OH)D of <20 ng/mL. As African ancestry is associated with decreased 25(OH)D but increased bone mineral density (BMD), the applicability of these thresholds to Africans is unknown. Therefore, we examined in African immigrants the relationship of 25(OH)D to parathyroid hormone (PTH) and BMD. METHODS: One hundred eighty-six African immigrants(69 % male, age 38 ± 10 (mean ± SD), range 20-64 years) living in metropolitan Washington, DC, were enrolled. BMD was determined from whole-body dual-energy X-ray absorptiometry (DXA) scans. Decreased BMD required T-scores ≤-1.0. The threshold for low 25(OH)D was the concentration of 25(OH)D at which PTH became suppressed. This is known as the inflection point. Biochemical deficiency required low 25(OH)D and PTH of >65 pg/mL. Clinical deficiency required low 25(OH)D and T-scores ≤-1.0. RESULTS: 25(OH)D <30 and <20 ng/mL occurred in 83 and 46 % of African immigrants, respectively. PTH inversely correlated with 25(OH)D (r = -0.31, P = 0.002). The inflection point occurred at a 25(OH)D concentration of 20 ng/mL. Biochemical and clinical deficiency occurred in only 8 and 3 % of immigrants, respectively. CONCLUSION: As PTH became suppressed at 25(OH)D of 20 ng/mL, the 25(OH)D <20 ng/mL threshold for insufficiency may apply to African immigrants. However, ~50 % of African immigrants have 25(OH)D <20 ng/mL, but only <10 % had evidence of deficiency. The value of providing vitamin D supplementation to the large number of African immigrants with 25(OH)D <20 ng/mL and no detectable evidence of deficiency needs to be determined.
UNLABELLED: African ancestry is associated with low vitamin D levels but high bone density. Fifty percent of African immigrants had low vitamin D levels, but <10 % had evidence of deficiency. The value of providing vitamin D supplementation to African immigrants without evidence of deficiency needs to be determined. INTRODUCTION: The Endocrine Society and Institute of Medicine (IOM) have concluded from studies in largely white populations that 25(OH)D is necessary for bone health. However, their definition of vitamin Dinsufficiency differs. The Endocrine Society recommends a 25(OH)D threshold of <30 ng/mL. The IOM uses a lower threshold of 25(OH)D of <20 ng/mL. As African ancestry is associated with decreased 25(OH)D but increased bone mineral density (BMD), the applicability of these thresholds to Africans is unknown. Therefore, we examined in African immigrants the relationship of 25(OH)D to parathyroid hormone (PTH) and BMD. METHODS: One hundred eighty-six African immigrants(69 % male, age 38 ± 10 (mean ± SD), range 20-64 years) living in metropolitan Washington, DC, were enrolled. BMD was determined from whole-body dual-energy X-ray absorptiometry (DXA) scans. Decreased BMD required T-scores ≤-1.0. The threshold for low 25(OH)D was the concentration of 25(OH)D at which PTH became suppressed. This is known as the inflection point. Biochemical deficiency required low 25(OH)D and PTH of >65 pg/mL. Clinical deficiency required low 25(OH)D and T-scores ≤-1.0. RESULTS:25(OH)D <30 and <20 ng/mL occurred in 83 and 46 % of African immigrants, respectively. PTH inversely correlated with 25(OH)D (r = -0.31, P = 0.002). The inflection point occurred at a 25(OH)D concentration of 20 ng/mL. Biochemical and clinical deficiency occurred in only 8 and 3 % of immigrants, respectively. CONCLUSION: As PTH became suppressed at 25(OH)D of 20 ng/mL, the 25(OH)D <20 ng/mL threshold for insufficiency may apply to African immigrants. However, ~50 % of African immigrants have 25(OH)D <20 ng/mL, but only <10 % had evidence of deficiency. The value of providing vitamin D supplementation to the large number of African immigrants with 25(OH)D <20 ng/mL and no detectable evidence of deficiency needs to be determined.
Entities:
Keywords:
African immigrants; Bone mineral density; Parathyroid hormone; Vitamin D
Authors: Clifford J Rosen; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; JoAnn E Manson; Susan T Mayne; A Catharine Ross; Sue A Shapses; Christine L Taylor Journal: J Clin Endocrinol Metab Date: 2012-03-22 Impact factor: 5.958
Authors: Laura A G Armas; Susan Dowell; Mohammed Akhter; Sowjanya Duthuluru; Christopher Huerter; Bruce W Hollis; Richard Lund; Robert P Heaney Journal: J Am Acad Dermatol Date: 2007-07-16 Impact factor: 11.527
Authors: Michelle Y O'Connor; Caroline K Thoreson; Natalie L M Ramsey; Madia Ricks; Anne E Sumner Journal: Prog Cardiovasc Dis Date: 2013 Nov-Dec Impact factor: 8.194
Authors: Heather M Ochs-Balcom; Leah Preus; Jean Wactawski-Wende; Jing Nie; Nicholas A Johnson; Fouad Zakharia; Hua Tang; Chris Carlson; Cara Carty; Zhao Chen; Thomas Hoffman; Carolyn M Hutter; Rebecca D Jackson; Robert C Kaplan; Li Li; Song Liu; Marian L Neuhouser; Ulrike Peters; John Robbins; Michael F Seldin; Timothy A Thornton; Cheryl L Thompson; Charles Kooperberg; Lara E Sucheston Journal: J Clin Endocrinol Metab Date: 2013-02-22 Impact factor: 5.958
Authors: Miguel Angel Luque-Fernandez; Bizu Gelaye; Tyler VanderWeele; Cynthia Ferre; Anna Maria Siega-Riz; Claudia Holzman; Daniel A Enquobahrie; Nancy Dole; Michelle A Williams Journal: Paediatr Perinat Epidemiol Date: 2013-12-20 Impact factor: 3.980
Authors: F Cosman; D C Morgan; J W Nieves; V Shen; M M Luckey; D W Dempster; R Lindsay; M Parisien Journal: J Bone Miner Res Date: 1997-06 Impact factor: 6.741
Authors: Camille E Powe; Michele K Evans; Julia Wenger; Alan B Zonderman; Anders H Berg; Michael Nalls; Hector Tamez; Dongsheng Zhang; Ishir Bhan; S Ananth Karumanchi; Neil R Powe; Ravi Thadhani Journal: N Engl J Med Date: 2013-11-21 Impact factor: 91.245
Authors: Susan D L Reed; Mary B Laya; Jennifer Melville; Sirad Y Ismail; Caroline M Mitchell; Diana R Ackerman Journal: J Womens Health (Larchmt) Date: 2007-03 Impact factor: 2.681
Authors: Christopher T Sempos; Ramón A Durazo-Arvizu; Bess Dawson-Hughes; Elizabeth A Yetley; Anne C Looker; Rosemary L Schleicher; Guichan Cao; Vicki Burt; Holly Kramer; Regan L Bailey; Johanna T Dwyer; Xinli Zhang; Jaime Gahche; Paul M Coates; Mary Frances Picciano Journal: J Clin Endocrinol Metab Date: 2013-05-10 Impact factor: 5.958
Authors: Anne E Sumner; Michelle T Duong; Paola C Aldana; Madia Ricks; Marshall K Tulloch-Reid; Jay N Lozier; Stephanie T Chung; David B Sacks Journal: Diabetes Care Date: 2015-12-17 Impact factor: 19.112